Product Pathways - Development
Snail (SN9H2) Rat mAb #4719
|4719S||100 µl (10 western blots)||---||In Stock||---|
|4719||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Monkey||Endogenous||29||Rat IgG2a|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting
Specificity / Sensitivity
Snail (SN9H2) Rat mAb detects endogenous levels of total Snail.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a recombinant human Snail protein.
Snail is a zinc-finger transcription factor that can repress E-cadherin transcription. Downregulation of E-cadherin is associated with epithelial-mesenchymal transition during embryonic development, a process also exploited by invasive cancer cells (1-3). Indeed, loss of E-cadherin expression is correlated with the invasive properties of some tumors and there is a considerable inverse correlation between Snail and E-cadherin mRNA levels in epithelial tumor cell lines (4,5). In addition, Snail blocks the cell cycle and confers resistance to cell death (6). Phosphorylation of Snail by GSK-3 and PAK1 regulates its stability, cellular localization and function (7-10).
- Barrallo-Gimeno, A. and Nieto, M.A. (2005) Development 132, 3151-3161.
- Cano, A. et al. (2000) Nat. Cell Biol. 2, 76-83.
- Batlle, E. et al. (2000) Nat. Cell Biol. 2, 84-89.
- Yokoyama, K. et al. (2003) Int. J. Oncol. 22, 891-898.
- Yokoyama, K. et al. (2001) Oral Oncol. 37, 65-71.
- Vega, S. et al. (2004) Genes Dev. 18, 1131-1143.
- Zhou, B.P. et al. (2004) Nat. Cell Biol. 6, 931-940.
- Bachelder, R.E. et al. (2005) J. Cell Biol. 168, 29-33.
- Yook, J.I. et al. (2005) J. Biol. Chem. 280, 11740-11748.
- Yang, Z. et al. (2005) Cancer Res. 65, 3179-3184.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.